We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC Probes Adderall Settlement Between Barr, Shire

Law360 (November 10, 2006, 12:00 AM EST) -- The U.S. Federal Trade Commission is probing an agreement between Barr Pharmaceuticals and Shire PLC that put to rest two patent lawsuits brought by Shire that sought to thwart Barr’s attempts to market a generic version of the hyperactivity drug Adderall XR.

The FTC has asked Barr to save all the documentation regarding the settlement, according to Barr’s Form 10-Q, filed with the U.S. Securities and Exchange Commission on Thursday. Barr said it intends to cooperate with the investigation.

In August, Barr and Shire struck a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.